Big Pharma Races Ahead With COVID-19 Vaccine!

There’s a new leader in the race to produce a COVID-19 vaccine. The latest entrant is the giant UK-based AstraZeneca company.

The drug maker is entering a third phase of testing, and hopes to be able to have the first doses of vaccine in October, with wider availability in 2021. However, there is no assurance the vaccine will actually be effective, safe, and get approval from regulatory agencies for use on the population. While early results are promising, there is no certainty the vaccine will work, or that it might become available before those from other companies, too.

Through its Biomedical Advanced Research and Development Authority (BARDA), the US has invested heavily in several vaccine development programmes, doling out over US$2.1 billion to pharmaceutical companies – both US-based and international – working on coronavirus vaccine development. So far, the grants are supporting vaccine development, testing, and scaling of production.

US president Donald Trump hopes that a vaccine would be ready for widespread use by the end of the year. Several pharmaceutical companies have encouraging early results, and have started testing potential vaccines.

Read More

Golf Is Back But Be Alert!

Asia has seen quite a few golf courses bounce back into business. In the weeks ahead, more will open up.

However, let us not drop our guard because the silent enemy is always there waiting to strike again.

The only way to beat the Coronavirus is to observe all of the safety and security protocols that have been prepared for the industry. Never let up on these safety measures.

Be prepared always for the fight. Never Give Up …. Don’t Ever Give Up!



Read More

Possible Cure Found For COVID-19?

Finally, there’s hope that a cure has been found for the dreaded Coronavirus which has claimed thousands of lives globally over the past three months.

There’s welcome news for golfers coming from the San Diego-based Sorrento Therapeutic which has announced that it has found an antibody in its vast library of stored antibodies that appears to be a cure.

Sorrento CEO Dr. Henry Ji (pictured) says its antibody, STI-1499, has provided 100% inhibition of the SARS-COV-2 virus in pre-clinical tests. Dr. Ji went so far as to call it a cure.

In order to broaden the potential effectiveness of this type of treatment, Sorrento has proposed a cocktail of three antibodies against COVID-19, attacking the virus at different weak points. To further that approach, Sorrento is partnering with Mount Sinai Hospital in New York to gain access to its more than 15,000 antibodies extracted from COVID patients.

If Sorrento gets US Federal Drug Administration approval for STI-1499, it says it can produce 200,000 doses a month, and will work to manufacture millions at risk, while FDA approval.

It is not known for sure until clinical trials prove its effectiveness and this may not take long, but this could be the breakthrough the world has been waiting for.

Meanwhile, American President Donald Trump has announced “Operation Warp Speed” to develop the COVID-19 vaccine as his administration mounted an unprecedented effort that involves the country’s military to get a vaccine for the deadly disease before the end of the year.

“It is called Operation Warp Speed that means big, and it means fast a massive scientific industrial and logistical endeavour, unlike anything our country has seen since the Manhattan Project,” according to Trump.

In concert with the US government effort are numerous programmes involving pharmaceutical companies all involved in an urgent hunt for a COVID-19 vaccine.

Read More